News

According to the company, TPI 1020 showed overall safety and tolerability, although its activity profile was not significantly different from budesonide, a conventional corticosteroid commonly used in respiratory

ALN-VSP contains two small interfering RNAs (siRNAs), the molecules that mediate RNAi, formulated in a lipid nanoparticle developed by Tekmira Pharmaceuticals. The proposed Phase I study is a

The letter was received following the company’s Class 1 resubmission in response to an October 2008 complete response letter. The company believes that no additional clinical trials will

The marketing authorization was granted by the European Commission for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation with: Intermediate-2 and high-risk

China Biologic has received sales orders on all the products that have been registered under the Central Drugs Standard Control Organization, the drug control administration in India. Those

DuraSite is a synthetic polymer of cross-linked polyacrylic acid that stabilizes small molecules in an aqueous matrix, allowing for targeted and sustained administration. By increasing the time that

Under a new distribution agreement, Abbott will exclusively distribute certain molecular diagnostic products manufactured by Celera. Under a second agreement, Celera will receive royalties on the sale of

Approximately 230 patients were enrolled to this study, randomized into three groups treated with 0.1mg and 4mg of CF101, and placebo. Patients are taking the drug for 12

According to the company, the new high-capacity immunoassay system provides laboratories with a new system to address their quality, labor and cost challenges. The Vitros 3600 is expected